2016
DOI: 10.17072/2218-9173-2016-1-113-132
|View full text |Cite
|
Sign up to set email alerts
|

Management of Investment Policy in the Enterprise Cluster

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Other negative trends in 2017-2019 were decreased R&D activity from 46.6 to 35.6% in the pharmaceutical industry and from 29.4% to 21.5% in the production of medical devices. However, in recent years, the pandemic has substantially boosted innovation in these areas [11].…”
Section: Status and Known Tools Of High-tech Clusters In Russiamentioning
confidence: 99%
See 1 more Smart Citation
“…Other negative trends in 2017-2019 were decreased R&D activity from 46.6 to 35.6% in the pharmaceutical industry and from 29.4% to 21.5% in the production of medical devices. However, in recent years, the pandemic has substantially boosted innovation in these areas [11].…”
Section: Status and Known Tools Of High-tech Clusters In Russiamentioning
confidence: 99%
“…However, this can be justified because over 75% of innovation clusters were launched after 2012. Therefore, they are still in the initial stage of formation or development, which implies the absence of progressive achievements in the context of innovative leadership or global competitiveness [11].…”
Section: Status and Known Tools Of High-tech Clusters In Russiamentioning
confidence: 99%